AI-Generated Genomes, Retinal Implants, and Palomar's Mystery Lights Explained
EP 15
·37:54

Story 2 starts — wireless retinal implant for AMD (PRIMA)

Watch AI-Generated Genomes, Retinal Implants, and Palomar's Mystery Lights Explained

Transcript

This chapter, from the episode video's captions · 296 words

37:54>> I was really excited to talk to you about this because um my undergrad uh my undergrad PhD thesis, not PhD, my undergrad bachelor's thesis in uh Princeton had to do with the retina. And you know, we were doing fundamental science, but this is a really cool story because it's it's out in NBC News. Fox News even covered it. Um, with a tiny eye implant and a set of glasses, we can now cure age related macular degeneration, >> which is crazy. >> Which is crazy, right? >> Yeah. That that >> the solution is pretty ridiculous. Now this to to be mindful this age related

38:37macular degeneration which is basically age related blindness in the center of your of your visual field. This had no prior restorative therapies. Right. This is the first of its kind that is trying to tackle that. Okay. >> So basically if you had AMD you were just >> Yeah. You were just you were just blind in the middle of your in the middle of your field. You could see in the peripheral but in the middle you couldn't see anything. And now we h actually have something that is restorative right not just slowing it down >> restorative. >> It brings it >> brings it back. That's >> okay. >> The solution is something called a prima system. It's a photovoltaic retina

39:18implant microarray. It's a novel neuroprothetic. So it's wireless. It's subretinal. And we're going to get into what what all that means. Okay. This was published in the New England Journal of Medicine. The key trial is called Prima Vera. I don't know if the authors are fans of the music festival in Barcelona, but that's what they called it, the Prima Vera.

From AI-Generated Genomes, Retinal Implants, and Palomar's Mystery Lights Explained

AI cancer genomes, bionic vision, and Palomar transient skepticism.